Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

Cancelled under Section 30(1)(c) of the Act

Clear all

24849 result(s) found, displaying 13276 to 13300

HOSPIRA PAPAVERINE HYDROCHLORIDE INJECTION papaverine hydrochloride 120 mg/10 mL injection ampoule Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
HOSPIRA PAPAVERINE HYDROCHLORIDE INJECTION papaverine hydrochloride 30 mg/1 mL injection ampoule Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Pfizer Australia Pty Ltd
LOVENOX enoxaparin sodium 100mg/1mL injection syringe Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 100mg/1mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 20mg/0.2mL injection syringe Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 20mg/0.2mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 40mg/0.4mL injection syringe Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 40mg/0.4mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 60mg/0.6mL injection syringe Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 60mg/0.6mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 80mg/0.8mL injection syringe Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX enoxaparin sodium 80mg/0.8mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX FORTE enoxaparin sodium 120mg/0.8mL injection syringe Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX FORTE enoxaparin sodium 120mg/0.8mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX FORTE enoxaparin sodium 150mg/1mL injection syringe Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
LOVENOX FORTE enoxaparin sodium 150mg/1mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
Reducta Cancelled under Section 30(1)(c) of the Act

22 March 2021

Cancellation by sponsor

Requested by Cat Media Pty Ltd
ALPHAPHARM BEZAFIBRATE 200mg tablet bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ALPHAPHARM SELEGILINE HYDROCHLORIDE 10mg tablet (AP3) bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ALPHAPHARM SELEGILINE HYDROCHLORIDE 5mg (AF2) tablet bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
ALPHAPHARM SELGILINE HYDROCHLORIDE 5mgMG (AF3) tablet bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
Alprazolam 0.25 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
Alprazolam 0.5 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
Alprazolam 1 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd
Alprazolam 2 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

19 March 2021

Cancellation by sponsor

Requested by Alphapharm Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

HOSPIRA PAPAVERINE HYDROCHLORIDE INJECTION papaverine hydrochloride 120 mg/10 mL injection ampoule Cancelled under Section 30(1)(c) of the Act

HOSPIRA PAPAVERINE HYDROCHLORIDE INJECTION papaverine hydrochloride 30 mg/1 mL injection ampoule Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 100mg/1mL injection syringe Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 100mg/1mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 20mg/0.2mL injection syringe Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 20mg/0.2mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 40mg/0.4mL injection syringe Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 40mg/0.4mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 60mg/0.6mL injection syringe Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 60mg/0.6mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 80mg/0.8mL injection syringe Cancelled under Section 30(1)(c) of the Act

LOVENOX enoxaparin sodium 80mg/0.8mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

LOVENOX FORTE enoxaparin sodium 120mg/0.8mL injection syringe Cancelled under Section 30(1)(c) of the Act

LOVENOX FORTE enoxaparin sodium 120mg/0.8mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

LOVENOX FORTE enoxaparin sodium 150mg/1mL injection syringe Cancelled under Section 30(1)(c) of the Act

LOVENOX FORTE enoxaparin sodium 150mg/1mL injection syringe with automatic safety lock system Cancelled under Section 30(1)(c) of the Act

Reducta Cancelled under Section 30(1)(c) of the Act

ALPHAPHARM BEZAFIBRATE 200mg tablet bulk Cancelled under Section 30(1)(c) of the Act

ALPHAPHARM SELEGILINE HYDROCHLORIDE 10mg tablet (AP3) bulk Cancelled under Section 30(1)(c) of the Act

ALPHAPHARM SELEGILINE HYDROCHLORIDE 5mg (AF2) tablet bulk Cancelled under Section 30(1)(c) of the Act

ALPHAPHARM SELGILINE HYDROCHLORIDE 5mgMG (AF3) tablet bulk Cancelled under Section 30(1)(c) of the Act

Alprazolam 0.25 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

Alprazolam 0.5 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

Alprazolam 1 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

Alprazolam 2 mg Tablets Bulk Cancelled under Section 30(1)(c) of the Act

Is there anything wrong with this page?

Site notifications

Cancellations by sponsors

Filter results

Decision type

Date of effect

Is there anything wrong with this page?